CClinicalTrials.gg
Status unknownNCT03774225Updated Feb 18, 2019

The Influence of Manual and Verbal Guidance for Therapeutic Results in People With Parkinson's Disease

An interventional study of Virtual Reality with Manual and Verbal Guidance and Virtual Reality with No Manual and Verbal Guidance in Parkinson Disease, sponsored by University of Sao Paulo General Hospital. Status unknown at 2 sites in Brazil. Open to participants aged 50 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-02-18.

Sponsored by University of Sao Paulo General Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2018), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Dec 2017, registered Sep 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
49
Allocation
Randomized
Ages
50 Years to 75 Years
Sex
All
01

Study summary

A prospective, single-blind, parallel-group, randomised trial was conducted in Sao Paulo, Brazil. Thrid eight People with Parkinson's Disease were recruited and randomly allocated in two groups: Experimental Group (EG), that performed the balance and gait training based on games from Microsoft Xbox Kinect System ® (MXKS) supported by manual and verbal guidance (MVG) provided by a PT and a control group (CG) that performed an identical training with no MVG during the training.

Read the detailed description

It were recruited PPD in the "Brazil Parkinson Association" (BPA), a no-government association of PD care, where the assessments and intervention were performed from December 2017 to June 2018. The PPD were recruited by randomization from the BPA list of active patients and waiting list for PT intervention.

Outcome measures were obtained at up to three time points: before intervention, after 1 week and after 8 weeks of the end of intervention, the last time point was considered as a follow-up assessment. This study is in agreement with CONSORT guidelines for developing randomised trials . Primary measures was the functional balance evaluation by the Balance Evaluation Systems Test (BESTest) and Rapid Turn Test (RT Test), and gait performance assessed in the six-minute walk test and Gait test in 30 seconds. As secondary measures were used: Unified Parkinson's Disease Rate Scale (UPDRS), 5-Step Standing Passing Test (ST-DP5), International Falls Efficiency Scale (FES-I), Brazilian Version of the Freezing Scale March (FOGQ), Parkinson's Disease Quality of Life Questionnaire (PDQ-39), Geriatric Depression Scale (GDS-15).

All patients performed 8 individual training sessions, under the supervision of a physiotherapist, twice a week for four weeks. Each session had 10 minutes of identical global exercises for both groups, consisting of stretching, muscle strengthening and axial mobility exercises, one serie per session. After these initial 10 minutes, both groups performed an additional 40 minutes of balance training using four XBOX games, four per session, under different conditions for MVG and NMVG.

While the Control Group will be trained by conventional Physical Therapy exercises.

02

Conditions studied

  • Parkinson Disease

Browse trials for

Keywords

  • Virtual Reality
  • International Classification of Functioning
  • Disability and Health
  • Rehabilitation
  • Gait
  • Balance
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 49 is above the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

University of Sao Paulo General Hospital is the lead sponsor of 595 studies on the registry; 98 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Parkinson's disease diagnosis according to Parkinson's Disease Society Brain Bank of London criteria
  • Active treatment with levodopa
  • Classification in stages 1, 2 and 3 according to Hoehn and Yahr Classification

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment defined as ≤ 20 in Montreal Cognitive Assessment
  • Severe respiratory and / or cardiovascular conditions
  • Visual and / or auditory deficit that can not be corrected with orthotics;
  • Other previously detected orthopedic or neurological diseases, other than Parkinson's Disease, that may interfere with the individual's performance;
  • Previous experience with Microsoft XBOX Kinect® games;
  • Be in rehab at another location concomitant with study training.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
49 participants (actual)

Study arms

  • Experimental
    Manual and verbal guidance (MVG)

    The MVG Group will be done by experimental group with the manual and verbal guidance of a physiotherapist using four games of X-Box Kinect system®

    Other: Virtual Reality with Manual and Verbal Guidance · Other: Virtual Reality with No Manual and Verbal Guidance · Other: Physical Therapy

  • Experimental
    No manual and verbal guidance (NMVG)

    The NMVG Group will be done by experimental group using four games of X-Box Kinect system® in the presence of a physiotherapist that will care about the safety of the participants without interfere in their moviment pattern.

    Other: Virtual Reality with Manual and Verbal Guidance · Other: Virtual Reality with No Manual and Verbal Guidance · Other: Physical Therapy

  • Active comparator
    Physical Therapy

    The Control Group will be trained by conventional Physical Therapy exercises.

    Other: Virtual Reality with Manual and Verbal Guidance · Other: Virtual Reality with No Manual and Verbal Guidance · Other: Physical Therapy

Interventions

  • OtherVirtual Reality with Manual and Verbal Guidance

    Participants will perform 4 balance games during 8 sessions with a manually and verbally assisted by a experient physiotherapist.

    Also known as: Experimental Group with Manual and Verbal Guidance (MVG)

  • OtherVirtual Reality with No Manual and Verbal Guidance

    Participants will perform 4 balance games during 8 sessions in the presence of a experient physiotherapist that will ensure patient safety, providing motivational verbal stimuli, and replicating the feedback provided by the game.

    Also known as: Experimental Group with No Manual and Verbal Guidance (NMVG)

  • OtherPhysical Therapy

    Patients of the control group will be trained with balance exercises by a experient physiotherapist.

    Also known as: Control Group

06

What researchers measure

Primary outcomes

  1. Change in Functional balance and gait with Best Test

    A scale consisting of 36 items, the score having a variation in four levels, 0 being the worst performance and 3 the best, with a total score of 108. This scale evaluates the balance under six different domains: biomechanical changes, stability / verticality limits, anticipatory postural adjustments, postural responses, sensory orientation and gait stability

    Time frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)

  2. Change in Gait with 6 minut walk test

    a gait assessment method that measures the maximum distance a person can walk and measures maximal cardiorespiratory functions

    Time frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)

  3. Change in Functional balance with Rapid turn test

    Is a mesure of dynamic balance. The subject tested turns in a complete circle (360 degrees) as faster as it could while time to finshed the turn is recorded. The test is done for both sides (right and left).

    Time frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)

Secondary outcomes

  1. Specific motor and non-motor aspects of Parkinson's disease with UPDRS scale

    It's a scale composed of four parts: Part I (non-motor aspects of daily life), Part II (motor aspects of daily life), Part III (motor evaluation) and Part IV (motor complications)

    Time frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)

  2. Risk of falls with FES-I scale

    presents questions about the concern with the possibility of falling when performing 16 activities, with respective scores from one to four. The total score can range from 16 (no concern) to 64 (extreme worry)

    Time frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)

  3. Endurance with 6 minut walk test

    a gait assessment method that measures the maximum distance a person can walk and measures maximal cardiorespiratory functions

    Time frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)

07

Study locations

2 sites
  • Brazil Parkinson Association
    São Paulo, 04142-092, Brazil
  • Department of Physiotherapy, Communication Science & Disorders, Occupational Therapy, School of Medicine, University of São Paulo
    São Paulo, 05360-160, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03774225
Lead sponsor
University of Sao Paulo General Hospital
Responsible party
Sponsor
First posted
Dec 12, 2018
Start date
Dec 1, 2017
Primary completion
Apr 30, 2018
Completion
Jul 20, 2019 (estimated)
Last update
Feb 18, 2019

Study contacts

Maria Elisa P Piemonte
principal investigator · University of Sao Paulo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion